SUNFLU Tablet (2021)
Βιβλιογραφική αναφορά
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Περιεχόμενα
1. Name of the medicinal product
SUNFLU TABLET.
2. Qualitative and quantitative composition
<u>Each tablet contains:</u> Paracetamol 500 mg Caffeine 12.5 mg Chlorpheniramine maleate 2 mg Phenylephrine HCL 5 mg
3. Pharmaceutical form
Tablet.
4.1. Therapeutic indications
It is indicated for the relief of nasal congestion as well as fevers, aches, pains and general discomfort associated with colds and upper respiratory infections.
4.2. Posology and method of administration
<u>Adults:</u> Two tablets every four hours, not to exceed 8 tablets in 24 hours.
4.3. Contraindications
It is contraindicated in patients who are hypersensitive to any of the ingredients. Due to the component phenylephrine, it is contraindicated in patients with ventricular tachycardia or severe hypertension. ...
4.4. Special warnings and precautions for use
Alcoholic beverages and driving a motor vehicle or operating heavy machinery should be avoided while taking this product. May cause drowsiness or excitability, especially in children. Persons with asthma, ...
4.8. Undesirable effects
<u>Adverse reactions to phenylephrine hydrochloride include:</u> Headache, reflex bradycardia, excitability, restlessness and rarely arryhthmias. <u>Adverse reactions to chlorpheniramine maleate include: ...
4.9. Overdose
Phenylephrine hydrochloride Overdosage may induce ventricular extrasystoles and short paroxysms of ventricular tachycardia, a sensation of fullness in the head and tingling of the extremities. Should an ...
6.4. Special precautions for storage
Keep the medicine in airtight container and store in a cool, dry place. Protect from light.
7. Marketing authorization holder
Sunward Pharmaceutical Pte.Ltd., 11, Wan Lee Road, Singapore, 627943
10. Date of revision of the text
22/02/2021
Πηγαίο έγγραφο
Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:
